BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
X-WR-TIMEZONE:America/New_York
BEGIN:VEVENT
LOCATION:
SUMMARY:Defining Antibiotic Stewardship & Associated HEDIS Measures
DESCRIPTION:About this Webinar Training\n\nCost: Free\nDate: Tuesday\, 
 August 16\, 2022\; 1-2pm ET\nThis course is open for 
 Pre-registration. Content will be available in 
 August.\nDefining Antibiotic Stewardship and Reviewing 
 Associated HEDIS® MeasuresInappropriate antibiotic use is a 
 long-standing public health issue. An estimated 30% of 
 outpatient antibiotic prescriptions are inappropriate. 
 Antibiotic stewardship aims to improve how antibiotics are 
 prescribed by clinicians and used by patients. 
 HEDIS® includes three measures that assess antibiotic 
 prescribing for bronchitis/bronchiolitis\, upper respiratory 
 infection and pharyngitis - three conditions that drive 
 significant levels of inappropriate prescribing in the U.S. 
 These measures provide a framework for health plans to use 
 their claims\, pharmacy\, and clinical data to identify\, 
 prioritize and monitor antibiotic stewardship 
 efforts.\nSubject matter experts will provide an overview 
 and updates on:\nAntibiotic stewardshipThree HEDIS 
 antibiotic measuresHEDIS antibiotic measure performanceWhat 
 You Will Learn\n\nAt the conclusion of the course\, learners 
 will be able to:\nDefine the critical importance of 
 antibiotic use and stewardship.Understand the importance of 
 three HEDIS antibiotic measures\, including how these 
 measures have changed over time.Describe health plan 
 performance from MY 2020. \nHEDIS® is a registered 
 trademark of the National Committee for Quality Assurance 
 (NCQA). Who Should Attend\n\nConsultantsFederal and state 
 government agenciesHealth care decision makersHealth care 
 professionalsHealth centers/health practicesHealth 
 plansHealth systemsHospitalsPopulation health 
 organizationsFaculty\n\nSepheen Byron\, DRPH\, MHSSepheen 
 Byron is Assistant Vice President\, Performance Measurement\, 
 at the National Committee for Quality Assurance (NCQA). She 
 oversees measure development and use of HEDIS and other 
 national evaluation programs and has developed measures used 
 by NCQA for Accreditation\, benchmarking and ratings. She 
 also led measure development for Medicaid and CHIP enrollees 
 as part of NCQA’s AHRQ-CMS Pediatric Quality Measures 
 Program Center of Excellence. Ms. Byron is the subject 
 matter expert for measures in the area of antibiotic 
 stewardship\, and recently led a project to broaden HEDIS 
 antibiotic measures to additional populations.\nPrior to 
 NCQA\, Ms. Byron was an Analyst in the Center for Outcomes 
 and Evidence at the Agency for Healthcare Research and 
 Quality\, where she assessed the effectiveness of health 
 services.\nMs. Byron has a BA from the University of 
 Virginia\, an MHS from the Johns Hopkins University Bloomberg 
 School of Public Health\, and a DrPH from the Gillings School 
 of Global Public Health\, University of North Carolina at 
 Chapel Hill.\n \nNancy McGee\, MS\, MBANancy A. McGee is an 
 Assistant Director in the Research and Analysis Department 
 at the National Committee for Quality Assurance (NCQA). She 
 is responsible for the development and maintenance of HEDIS 
 measures primarily addressing geriatric health care. She has 
 also worked on research efforts focused on person-driven 
 outcomes for individuals with serious illness\, multiple 
 chronic conditions and disabilities.\nPrior to joining NCQA\, 
 Ms. McGee worked in employee benefits\, including as a 
 benefits manager for a national employee organization\; as a 
 Health and Benefits Consultant for Mercer\; and as a Project 
 Manager implementing benefits administration systems for ADP 
 and Ceridian.\nMs. McGee has an MS in Gerontology from the 
 University of Utah School of Nursing and an MBA from the 
 David Eccles School of Business at the University of 
 Utah.\nContinuing Education\n\nIn support of improving 
 patient care\, the National Committee for Quality Assurance 
 is jointly accredited by the Accreditation Council for 
 Continuing Medical Education (ACCME)\, the Accreditation 
 Council for Pharmacy Education (ACPE)\, the American Nurses 
 Credentialing Center (ANCC) to provide Interprofessional 
 Continuing Education for the healthcare team. \nThis 
 activity was planned by and for the healthcare team\, and 
 learners will receive 1.0 Interprofessional Continuing 
 Education (IPCE) credit for learning and change.\nThis 
 educational activity is approved for a maximum of 1.0 AMA 
 PRA Category 1 Credit™\, and ACPE. \nThis educational 
 activity is approved for 1.0 nursing contact hours.*\nThe 
 assigned universal program number: 
 JA0004597-0000-22-020-L04-P. Upon successful completion of 
 this program (attending the full session and completing a 
 program evaluation)\, participants will access CPE Monitor on 
 the ACPE website to locate and track their CPE statement of 
 credit.\nThis live course grants 1.0 Continuing Education 
 Unit (CEU) points for PCMH Certified Content 
 Experts.  \n* Please note – You must attend the entire 
 program to be eligible for total number of contact 
 hours.\nNABP Credit Reporting If you are a pharmacist 
 completing a course offering CPE credits\, please notify NCQA 
 through ncqa.org within 14 calendar days that you have 
 completed a CPE course. You must provide the title of the 
 course\, your NABP identification number and your DOB 
 (month/date) within the notification to NCQA. We also 
 recommend you update your education.ncqa.org profile with 
 your NABP identification number.  \nDisclosure of Relevant 
 Financial RelationshipsThe National Committee for Quality 
 Assurance (NCQA) endorses the Standards of the Accreditation 
 Council for Continuing Medical Education which specify that 
 sponsors of continuing medical education activities and 
 presenters at and planners for these activities disclose any 
 relevant financial relationships either party might have 
 with commercial companies whose products or services are 
 discussed in educational presentations.\nFor sponsors\, 
 relevant financial relationships include large research 
 grants\, institutional agreements for joint initiatives\, 
 substantial gifts\, or other relationships that benefit the 
 institution.  For presenters or planning committee members\, 
 relevant financial relationships include the receipt of 
 research grants from a commercial company\, consultancies\, 
 honoraria\, travel\, or other benefits\, or having a 
 self-managed equity interest in a company\; or having an 
 immediate family member or partner with such a 
 relationship.\nDisclosure of a relationship is not intended 
 to suggest or condone bias in any presentation but is made 
 to provide participants with information that might be of 
 potential importance to their evaluation of a 
 presentation.\nRelevant financial relationships exist with 
 the following companies/organizations:\nFaculty:\nSepheen 
 Byron: Dr. Byron received funding from the Centers for 
 Disease Control and Prevention (contract no. 75D30120C08243) 
 to develop the measure related to antibiotic 
 utilization.\nAdditional Planning Committee Members:\nAshley 
 Turner: None\nNancy McGee: None\nSepheen Byron: Dr. Byron 
 received funding from the Centers for Disease Control and 
 Prevention (contract no. 75D30120C08243) to develop the 
 measure related to antibiotic utilization.\n\n\nThis program 
 was developed in part by NCQA 
 staff.\nAcknowledgement\nSupport for this project was 
 provided by The Pew Charitable Trusts.\nDisclaimer\n“The 
 views expressed are those of the author(s) and do not 
 necessarily reflect the views of The Pew Charitable 
 Trusts”.\n
DTSTART:20220816T130000
DTEND:20220816T140000
URL;VALUE=URI:
DTSTAMP:20260507T034145
UID:69fc42397c4f3
END:VEVENT
END:VCALENDAR